A novel murine model for keratoprosthesis.
暂无分享,去创建一个
R. Dana | J. Graney | C. Dohlman | A. Črnej | Thomas H. Dohlman | B. Drnovšek-Olup | Masahiro Omoto | B. Drnovšek‐Olup
[1] Rony R. Sayegh,et al. Very Low Risk of Light-Induced Retinal Damage During Boston Keratoprosthesis Surgery: A Rabbit Study , 2014, Cornea.
[2] A. Shukla,et al. Wound Anatomy After Type 1 Boston KPro Using Oversized Back Plates , 2013, Cornea.
[3] I. Gipson,et al. In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. , 2013, Investigative ophthalmology & visual science.
[4] Michael W. Belin,et al. Retention of the Boston keratoprosthesis type 1: multicenter study results. , 2013, Ophthalmology.
[5] S. Schwartz,et al. POSTOPERATIVE POSTERIOR SEGMENT COMPLICATIONS IN EYES TREATED WITH THE BOSTON TYPE I KERATOPROSTHESIS , 2013, Retina.
[6] M. S. Cortina,et al. Visual Outcomes of Boston Keratoprosthesis Implantation as the Primary Penetrating Corneal Procedure , 2012, Cornea.
[7] F. Yu,et al. International results with the Boston type I keratoprosthesis. , 2012, Ophthalmology.
[8] S. Kiss,et al. Vitreoretinal surgery in the setting of permanent keratoprosthesis. , 2012, Archives of ophthalmology.
[9] D. Ritterband,et al. Boston type 1 keratoprosthesis: the New York Eye and Ear experience , 2012, Eye.
[10] J. Stein,et al. Glaucoma Associated With Boston Type I Keratoprosthesis , 2012, Cornea.
[11] M. Harissi-Dagher,et al. Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery. , 2012, American journal of ophthalmology.
[12] C. Grosskreutz,et al. Glaucoma in Eyes With Severe Chemical Burn, Before and After Keratoprosthesis , 2011, Cornea.
[13] Liqiang Wang,et al. Biocompatibility and biofilm inhibition of N,N-hexyl,methyl-polyethylenimine bonded to Boston Keratoprosthesis materials. , 2011, Biomaterials.
[14] Tueng T. Shen,et al. Global corneal blindness and the Boston keratoprosthesis type I. , 2010, American journal of ophthalmology.
[15] E. Myrowitz,et al. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation. , 2010, Ophthalmology.
[16] K. Tsubota,et al. Retinal phototoxicity in a novel murine model of intraocular lens implantation , 2009, Molecular vision.
[17] M. Durand,et al. Successful Prevention of Bacterial Endophthalmitis in Eyes with the Boston Keratoprosthesis , 2009, Cornea.
[18] R. Pineda,et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. , 2007, American journal of ophthalmology.
[19] James V Aquavella,et al. Introduction to the use of the Boston keratoprosthesis , 2006 .
[20] P. Tsonis,et al. Lens regeneration in mice: implications in cataracts. , 2004, Experimental eye research.
[21] J. Forrester,et al. A new model of posterior capsule opacification in rodents. , 2003, Investigative ophthalmology & visual science.
[22] B. Khan,et al. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. , 2002, The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc.
[23] M. Durand,et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. , 2001, Archives of ophthalmology.
[24] Bonnie Salomon,et al. Procedure , 2001, The Lancet.
[25] M. Doane,et al. Keratoprosthesis: Preoperative Prognostic Categories , 2001, Cornea.
[26] P. Netland,et al. Glaucoma associated with keratoprosthesis. , 1998, Ophthalmology.